Featured Research

from universities, journals, and other organizations

Decoy Pill Saves Brain Cells, May Lead To Neuroprotective Drugs For Stroke And Alzheimer's Patients

Date:
February 2, 2007
Source:
University of Southern California
Summary:
A decoy version of a brain receptor fools a toxic enzyme, breaking a feedback loop that leads to widespread neuron death in stroke, Alzheimer's and other degenerative diseases.

Tricking a key enzyme can soothe over-excited receptors in the brain, say neuroscientists, calling this a possible strategy against stroke, Alzheimer's and other neurodegenerative diseases.

Lead author Michel Baudry of the University of Southern California, his graduate student Wei Xu and collaborators from the University of British Columbia outline their technique in the Feb. 1 issue of Neuron.

The researchers injected laboratory mice with a decoy peptide containing a snippet of a receptor that facilitates cell death in neurodegenerative diseases.

They hoped the toxic enzyme calpain would latch on to the decoy instead of the actual receptor, averting brain damage.

As a test, the researchers then injected the mice with kainic acid, a chemical known to cause seizures and neuron death.

While seizures still occurred, as in control mice, no brain lesions were observed in the subjects.

"We eliminate a big chunk of neuronal death," Baudry said. "I was surprised that this works. It looks like the peptide is almost completely neuroprotective."

Baudry, one of USC's most frequently cited researchers, has been studying calpain and other chemicals in the brain for more than 20 years.

Scientists have known for decades that the neurotransmitter glutamate, which tells neurons to fire, can also destroy them. If over-activated, glutamate receptors start a chain reaction that raises the concentration of calcium and activates calpain, among other toxic enzymes.

But Baudry and Xu observed that in one receptor, mGluR1?, the situation is even worse. Under normal conditions, this receptor is neuroprotective. However, calpain truncates it and makes it neurodegenerative in such a way as to start a positive feedback loop that leads to ever-higher levels of calcium and continuous calpain activation.

In addition, by cutting mGluR1?, calpain eliminates its neuroprotective function.

The decoy, developed by Xu, reversed the outcomes. By tricking calpain, it prevented damage to the receptor and allowed the beneficial reaction to continue. In addition, it interrupted the feedback loop that stoked calpain activation.

"This is potentially a treatment for any conditions that involve this kind of excitotoxicity," Baudry said, and especially, he added, for the "window of opportunity" in the few hours after a stroke.

While a stroke kills some brain cells right away, others take much longer to die. If the stroke triggered a calcium-calpain feedback loop, treatment with decoy peptides might save some cells, Baudry said.

His group plans to test the treatment in a stroke model in mice.

Funding for this research came from a grant from the National Institute for Neurodegeneration and Stroke.


Story Source:

The above story is based on materials provided by University of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University of Southern California. "Decoy Pill Saves Brain Cells, May Lead To Neuroprotective Drugs For Stroke And Alzheimer's Patients." ScienceDaily. ScienceDaily, 2 February 2007. <www.sciencedaily.com/releases/2007/01/070131135541.htm>.
University of Southern California. (2007, February 2). Decoy Pill Saves Brain Cells, May Lead To Neuroprotective Drugs For Stroke And Alzheimer's Patients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/01/070131135541.htm
University of Southern California. "Decoy Pill Saves Brain Cells, May Lead To Neuroprotective Drugs For Stroke And Alzheimer's Patients." ScienceDaily. www.sciencedaily.com/releases/2007/01/070131135541.htm (accessed July 22, 2014).

Share This




More Mind & Brain News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Do Obese Women Have 'Food Learning Impairment'?

Do Obese Women Have 'Food Learning Impairment'?

Newsy (July 18, 2014) Yale researchers tested 135 men and women, and it was only obese women who were deemed to have "impaired associative learning." Video provided by Newsy
Powered by NewsLook.com
Does Mixing Alcohol and Energy Drinks Boost Urge To Drink?

Does Mixing Alcohol and Energy Drinks Boost Urge To Drink?

Newsy (July 18, 2014) A new study suggests that mixing alcohol with energy drinks makes you want to keep the party going. Video provided by Newsy
Powered by NewsLook.com
Pot Cooking Class Teaches Responsible Eating

Pot Cooking Class Teaches Responsible Eating

AP (July 18, 2014) Following the nationwide trend of eased restrictions on marijuana use, pot edibles are growing in popularity. One Boston-area cooking class is teaching people how to eat pot responsibly. (July 18) Video provided by AP
Powered by NewsLook.com
Understanding D.C.'s New Pot Laws

Understanding D.C.'s New Pot Laws

Newsy (July 17, 2014) Washington D.C.'s new laws decriminalizing small amount of marijuana went into effect Thursday. Here's how they work. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins